Devices and methods for frequent measurement of an analyte present in a biological system

• US 7,163,511 B2
• Filed: 01/29/2003
• Issued: 01/16/2007
• Est. Priority Date: 02/12/1999
• Status: Expired due to Term

• Current Assignee: LifeScan IP Holdings, LLC
• Original Assignee: Animas Technologies LLC (Johnson & Johnson)
• Inventors: Potts, Russell O., Tamada, Janet A., Tierney, Michael J., Soni, Pravin L., Ford, Russell, Conn, Thomas E.
• Primary Examiner(s): Winakur; Eric F.
• Application Number:
  US10/353,400
• Publication Number:
  US 20030144581A1
• Time in Patent Office: 1,448 Days
• Field of Search: 600309-310, 600/347, 600322-326, 600354-365
• US Class Current: 600/309
• CPC Class Codes: A61B 5/0002 Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network A61B5/07 takes precedence; transmission systems for measured values G08C; transmission H04B; transmission of digital information H04L; wireless communication networks H04W
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 5/681 Wristwatch-type devices
• CPC Class Codes: A61B 5/6831 Straps, bands or harnesses

Abstract

Devices and methods are provided for frequently measuring the concentration of an analyte present in a biological system. A monitoring system having at least two components is employed in order to allow separation of data collection from data processing and display. Such separation allows greater flexibility and convenience for the user.

Claims

1. A monitoring system for frequently measuring an analyte present in a subject and providing to said subject self-monitoring of said analyte, said monitoring system comprising:

(A) a first component to be placed in contact with a skin or mucosal surface of said subject comprising

(i) a sampling mechanism for transdermally extracting the analyte from the subject, wherein said sampling mechanism is adapted for extracting the analyte across a skin or mucosal surface of said subject;

(ii) a sensing mechanism in operative contact with the analyte extracted by the sampling mechanism, wherein said sensing mechanism obtains a signal from the extracted analyte and said signal is specifically related to an amount or concentration of analyte; and

(iii) a first mechanism for providing operative communication with a second component of the monitoring system, wherein (a) said operative communication comprises wireless communication technology employing electromagnetic waves, and (b) said first and second components are separately housed; and

(B) the second component comprising

(i) a user interface;

(ii) a second mechanism for providing operative communication with the first component, wherein (a) said operative communication comprises wireless communication technology employing electromagnetic waves, (b) the second component receives the signal from the first component, and (c) is capable of communicating with a third component remote from the subject being monitored without communicating with the first component;

(iii) a computing mechanism that converts the signal from the extracted analyte to an output indicative of the amount or concentration of analyte extracted by the sampling mechanism;

(iv) a visual display said output to the subject;

(v) an alarm that produces tactile and/or auditory signals to warn the subject when the amount or concentration of analyte is above a pre-set threshold value or below a pre-set threshold value; and

(vi) the second component configured to be worn by the subject on a wrist of the subject or a belt of the subject, or configured to be carried by the subject as a credit-card-type unit or a pager-type unit.

2. The monitoring system of claim 1, wherein the wireless communication technology employs low frequency electromagnetic waves in a frequency range of about 1 Hz. to about 1 Mega Hz.

3. The monitoring system of claim 1, wherein the wireless communication technology employs medium frequency electromagnetic waves in a frequency range of about 1 Mega Hz. to about 500 Mega Hz.

4. The monitoring system of claim 1, wherein the wireless communication technology employs high frequency electromagnetic waves in a frequency range of about 500 Mega Hz. to about 5 Giga Hz.

5. The monitoring system of claim 1, wherein the wireless communication technology employs capacitance coupling between the subject and subject'"'"'s environment.

6. The monitoring system of claim 1, wherein the wireless communication technology employs inductive coupling.

7. The monitoring system of claim 1, wherein the wireless communication technology employs infrared coupling.

8. The monitoring system of claim 1, wherein the second component relays command signals to the first component.

9. The monitoring system of claim 8, wherein the command signals include signals to control operation of the sensing mechanism.

10. The monitoring system of claim 8, wherein the command signals include signals to control operation of the sampling mechanism.

11. The monitoring system of claim 1, wherein the second component is capable of storing analyte-related data.

12. The monitoring system of claim 1, wherein the analyte comprises glucose.

13. The monitoring system of claim 1, wherein said subject is a mammal.

14. The monitoring system of claim 13, wherein said mammal is a human.

15. The monitoring system of claim 1, further comprising

(C) a delivery device component comprising

(i) a delivery device;

and

(ii) a third mechanism for providing operative communication with the first and second components, wherein the communication between first and second components and the third component is wireless.

16. The monitoring system of claim 15, wherein the delivery device is adapted to be implanted in the subject.

17. The monitoring system of claim 15, wherein the delivery device is adapted to be external to the subject.

18. The monitoring system of claim 15, wherein the delivery device comprises an insulin pump.

19. The monitoring system of claim 1, wherein

(C) the third component comprises

(i) a modem or personal computer;

and

(ii) a third mechanism for providing operative communication with the first and second components, wherein said operative communication comprises wireless communication technology that employs electromagnetic waves.

20. The monitoring system of claim 19, wherein the analyte comprises glucose.

21. The monitoring system of claim 19, wherein the modem or personal computer is operably linked to a wide area network (WAN).

22. The monitoring system of claim 1 wherein the second component includes buttons for controlling, by the subject, data sampling intervals of the first component and buttons for controlling, by the subject, data manipulation and display in the second component.

23. A method for self-monitoring of analyte present in a subject, the method comprising the steps of:

(a) placing a first component in contact with a skin or mucosal surface of the subject;

(b) transdermally extracting analyte from the skin or mucosal surface of the subject, by the first component;

(c) obtaining a signal, by the first component, specifically related to an amount or concentration of the analyte;

(d) providing the subject a second component adapted to be worn or carried;

(e) wirelessly communicating, using electromagnetic waves, between the first component and the second component;

(f) receiving, by the second component, the signal obtained in step (c) from the first component;

(g) computing, by the second component, the amount or concentration of the analyte extracted by the first component;

(h) visually displaying to the subject a warning, by the second component, if the amount or concentration of analyte is above or below a pre-set threshold value; and

(i) audibly alarming the subject, by the second component, if the amount or concentration of analyte is above or below a pre-set threshold value.

24. The method of claim 23 including the following step:

controlling, by the subject, data sampling intervals of the first component and data manipulation and display of the second component.

25. The method of claim 23 including the step of:

wirelessly transmitting by the second component to a remote third component the amount or concentration of analyte computed by the second component.